EVALUATION OF THE EFFICACY AND SAFETY OF A HUMAN RECOMBINANT ACTIVATED FACTOR VII (HRFVIIA) PREPARATION IN A PEDIATRIC PATIENT WITH GLANZMANN THROMBASTHENIA

被引：0
|
作者：
Szamosujvari, J. [1 ]
Losonczy, G. [2 ]
Muszbek, L. [2 ]
Kappelmayer, J.
Kiss, C. [1 ]
机构：
[1] Inst Pediat, Dept Pediat Hematol Oncol, Debrecen, Hungary
[2] Univ Debrecen, Clin Res Ctr, Debrecen, Hungary
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2009年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1331
引用
收藏
页码：526 / 527
页数：2
相关论文
共 50 条
  • [41] Efficacy and safety of recombinant activated factor VII in the management of hemorrhagic shock due to trauma
    Hauser, C. J.
    Boffard, K. D.
    Dutton, R. P.
    GR, Bernard
    Croce, M. A.
    Holcomb, J. B.
    Leppaniemi, A. K.
    Parr, M. J. A.
    Vincent, J. L.
    Tortella, B. J.
    Dimsits, J.
    Bouillon, B.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 290 - 291
  • [42] Intraoral Hemostasis using a recombinant activated factor VII preparation in a hemophilia A patient with inhibitor
    Morimoto, Y
    Yoshioka, A
    Shima, M
    Kirita, T
    JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2003, 61 (09) : 1095 - 1097
  • [43] Comparison of efficacy and safety between aryogen recombinant activated factor VII (Aryoseven™) and Novoseven® in the main on-label (approved) indications of recombinant activated factor VII in Iran
    Eshghi, P.
    Kamyar, K.
    Abolghasemi, H.
    Karimi, M.
    Faranoush, M.
    Toogeh, G.
    Hoorfar, H.
    Dehdezi, B. K.
    Khoeiny, B.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 : 30 - 30
  • [44] Safety and efficacy of recombinant activated factor VII for refractory hemorrhage in pediatric patients on extracorporeal membrane oxygenation: a single center review
    Long, M. T.
    Wagner, D.
    Maslach-Hubbard, A.
    Pasko, D. A.
    Baldridge, P.
    Annich, G. M.
    PERFUSION-UK, 2014, 29 (02): : 163 - 170
  • [45] Use of recombinant factor VIIA for post-operative haemorrhage in a patient with Glanzmann's thrombasthenia and human leucocyte antigen antibodies
    Patel, RK
    Savidge, GF
    Rangarajan, S
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 114 (01) : 245 - 246
  • [46] SAFETY AND EFFICACY OF OFF-LABEL USE OF RECOMBINANT ACTIVATED FACTOR VII IN CARDIOTHORACIC SURGERY
    Walla, Danielle
    Johnson, Manda
    Baek, Grace
    Schanz, Caitlin
    Pham, Lily
    CRITICAL CARE MEDICINE, 2020, 48
  • [47] Recombinant Activated Factor VII as a General Haemostatic Agent: Evidence-Based Efficacy and Safety
    Squizzato, Alessandro
    Ageno, Walter
    CURRENT DRUG SAFETY, 2007, 2 (02) : 155 - 161
  • [48] Efficacy and questionable safety of recombinant activated factor VII in intractable bleeding following cardiac surgery
    Tong, M. Z.
    Chin-Yee, I.
    Eckert, K.
    Kiaii, B.
    Quantz, M.
    Novick, R. J.
    CANADIAN JOURNAL OF CARDIOLOGY, 2007, 23 : 291C - 291C
  • [49] Recombinant activated factor VII to control bleeding in cardiovascular surgery: need of efficacy and safety validation
    Blanloeil, Y
    Rigal, JC
    Bastien, O
    Carteau, JP
    Toussaint-Hacquard, M
    Lecompte, T
    ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION, 2006, 25 (01): : 2 - 5
  • [50] INTRAPULMONARY INSTILLATION OF RECOMBINANT ACTIVATED FACTOR VII IN A PEDIATRIC ONCOLOGY PATIENT WITH DIFFUSE ALVEOLAR HEMORRHAGE
    Khan, Nadia
    McLaughlin, Gwenn
    Andreansky, Martin
    Colin, Andrew
    Cantwell, G.
    CRITICAL CARE MEDICINE, 2009, 37 (12) : A522 - A522
12345